NGF – the TrkA to successful pain treatment

References

• HeftiFFRosenthalAWalickePANovel class of pain drugs based on antagonism of NGFTrends Pharmacol Sci2006272859116376998
   PubMed Web of Science ®Google Scholar
• JuliusDBasbaumAIMolecular mechanisms of nociceptionNature92001413685220321011557989
   PubMed Web of Science ®Google Scholar
• WatsonJJAllenSJDawbarnDTargeting nerve growth factor in pain: what is the therapeutic potential?Bio Drugs2008226349359
   Google Scholar
• WoodcockJA difficult balance – pain management, drug safety, and the FDAN Engl J Med2009361222105210719940297
   PubMed Web of Science ®Google Scholar
• CohenSOrigins of growth factors: NGF and EGFAnn N Y Acad Sci200410389810215838103
   PubMed Web of Science ®Google Scholar
• TuszynskiMHNerve growth factor gene delivery: animal models to clinical trialsDev Neurobiol20076791204121517514712
   PubMed Web of Science ®Google Scholar
• VaronSConnerJMNerve growth factor in CNS repairJ Neurotrauma19941154734867861441
   PubMed Web of Science ®Google Scholar
• EvansRJMoldwinRMCossonsNDarekarAMillsIWScholfieldDProof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitisJ Urol201118551716172121420111
   PubMed Web of Science ®Google Scholar
• FioreMChaldakovGNAloeLNerve growth factor as a signaling molecule for nerve cells and also for the neuroendocrine-immune systemsRev Neurosci200920213314519774790
   PubMed Web of Science ®Google Scholar
• ZhuWGaloyanSMPetruskaJCOxfordGSMendellLMA developmental switch in acute sensitization of small dorsal root ganglion (DRG) neurons to capsaicin or noxious heating by NGFJ Neurophysiol20049253148315215201308
   PubMed Web of Science ®Google Scholar
• HuangEJReichardtLFTrk receptors: roles in neuronal signal transductionAnnu Rev Biochem20037260964212676795
   PubMed Web of Science ®Google Scholar
• HoltzmanDMKilbridgeJLiYTrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neuronsJ Neurosci1995152156715767869118
   PubMed Web of Science ®Google Scholar
• BarrettGLThe p75 neurotrophin receptor and neuronal apoptosisProg Neurobiol200061220522910704998
   PubMed Web of Science ®Google Scholar
• LadSPPetersonDABradshawRANeetKEIndividual and combined effects of TrkA and p75NTR nerve growth factor receptors. A role for the high affinity receptor siteJ Biol Chem200327827248082481712702729
   PubMed Web of Science ®Google Scholar
• ZhangXHuangJMcNaughtonPANGF rapidly increases membrane expression of TRPV1 heat-gated ion channelsEMBO J200524244211422316319926
   PubMed Web of Science ®Google Scholar
• ZhuWOxfordGSPhosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1Mol Cell Neurosci4200734468970017324588
   PubMed Web of Science ®Google Scholar
• McMahonSBNGF as a mediator of inflammatory painPhilosophical Transactions: Biological Sciences199635113384314408730782
   PubMed Web of Science ®Google Scholar
• BonningtonJKMcNaughtonPASignalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factorJ Physiol2003551Pt 243344612815188
   PubMed Web of Science ®Google Scholar
• AverillSMcMahonSBClaryDOReichardtLFPriestleyJVImmunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neuronsEur J Neurosci199577148414947551174
   PubMed Web of Science ®Google Scholar
• Jimenez-AndradeJMMartinCDKoewlerNJNerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracturePain20071331–318319617693023
   PubMed Web of Science ®Google Scholar
• SevcikMAGhilardiJRPetersCMAnti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitizationPain20051151–212814115836976
   PubMed Web of Science ®Google Scholar
• KojimaMIkeuchiTHatanakaHRole of nerve growth factor in the expression of trkA mRNA in cultured embryonic rat basal forebrain cholinergic neuronsJ Neurosci Res19954267757838847739
   PubMed Web of Science ®Google Scholar
• SofroniewMVHoweCLMobleyWCNerve growth factor signaling, neuroprotection, and neural repairAnnu Rev Neurosci2001241217128111520933
   PubMed Web of Science ®Google Scholar
• KoltzenburgMBennettDLSheltonDLMcMahonSBNeutralization of endogenous NGF prevents the sensitization of nociceptors supplying inflamed skinEur J Neurosci19991151698170410215923
   PubMed Web of Science ®Google Scholar
• McMahonSBBennettDLPriestleyJVSheltonDLThe biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion moleculeNat Med1995187747807585179
   PubMed Web of Science ®Google Scholar
• McNameeKEBurleighAGompelsLLTreatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint painPain2010149238639220350782
   PubMed Web of Science ®Google Scholar
• CapsoniSCovaceuszachSMarinelliSTaking pain out of NGF: a “painless” NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activityPLoS One201162e1732121387003
   PubMed Web of Science ®Google Scholar
• IndoYTsurutaMHayashidaYMutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosisNat Genet19961344854888696348
   PubMed Web of Science ®Google Scholar
• LiuHTTyagiPChancellorMBKuoHCUrinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatmentBJU Int2009104101476148119522864
   PubMed Web of Science ®Google Scholar
• OchodnickýPCruzCDYoshimuraNMichelMCNerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic targetNeurourol Urodyn20113071227124121520250
   PubMed Web of Science ®Google Scholar
• RaychaudhuriSKRaychaudhuriSPNGF and its receptor system: a new dimension in the pathogenesis of psoriasis and psoriatic arthritisAnn N Y Acad Sci2009117347047719758188
   PubMed Web of Science ®Google Scholar
• WatanabeTInoueMSasakiKNerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatmentBJU Int2011108224825120883485
   PubMed Web of Science ®Google Scholar
• KuoHCLiuHTChancellorMBUrinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinenceNeurourol Urodyn201029348248719367641
   PubMed Web of Science ®Google Scholar
• BloomAPJimenez-AndradeJMTaylorRNBreast cancer-induced bone remodeling, skeletal pain, and sprouting of sensory nerve fibersJ Pain201112669871121497141
   PubMed Web of Science ®Google Scholar
• Jimenez-AndradeJMBloomAPStakeJIPathological sprouting of adult nociceptors in chronic prostate cancer-induced bone painJ Neurosci20103044146491465621048122
   PubMed Web of Science ®Google Scholar
• EvansLAndrewDRobinsonPBoissonadeFLoescherAIncreased cutaneous NGF and CGRP-labelled trkA-positive intra-epidermal nerve fibres in rat diabetic skinNeurosci Lett20125061596322044876
   PubMed Web of Science ®Google Scholar
• Jimenez-AndradeJMGhilardiJRCastañeda-CorralGKuskowskiMAMantyhPWPreventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer painPain2011152112564257421907491
   PubMed Web of Science ®Google Scholar
• SheltonDLZellerJHoWHPonsJRosenthalANerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritisPain20051161–281615927377
   PubMed Web of Science ®Google Scholar
• AbdicheYMalashockDSPonsJProbing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensorsProtein Science20081781326133518505735
   PubMed Web of Science ®Google Scholar
• MantyhPTiveLSheltonDTanezumab, a humanized anti-nerve growth factor antibody for the treatment of painThe Journal of Pain: Official Journal of the American Pain Society2009104S44
   Google Scholar
• CattaneoATanezumab, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic painCurr Opin Mol Ther20101219410620140821
   PubMedGoogle Scholar
• EkmanEGimbelJBelloAEfficacy and safety of intravenous tanezumab in osteoarthritis hip and knee pain: comparison to placebo and naproxen in two phase III studies (NCT00830063 and NCT00863304)The Journal of Pain: Official Journal of the American Pain Society2011124P55
   Google Scholar
• HaddleyKTanezumab. Anti-NGF monoclonal antibody, Treatment of pain, Treatment of osteoarthritisDrugs of the Future2010355373378
   Web of Science ®Google Scholar
• ZorbasMHurstSSheltonDEvansMFincoDButtMA multiple-dose toxicity study of tanezumab in cynomolgus monkeysRegul Toxicol Pharmacol201159233434221130822
   PubMed Web of Science ®Google Scholar
• LaneNESchnitzerTJBirbaraCATanezumab for the treatment of pain from osteoarthritis of the kneeN Engl J Med2010363161521153120942668
   PubMed Web of Science ®Google Scholar
• NagashimaHSuzukiMArakiSYamabeTMutoCPreliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled studyOsteoarthritis and Cartilage/OARS, Osteoarthritis Research Society2011191214051412
   Web of Science ®Google Scholar
• SchnitzerTJLaneNEBirbaraCSmithMDSimpsonSLBrownMTLong-term open-label study of tanezumab for moderate to severe osteoarthritic knee painOsteoarthritis Cartilage201119663964621251985
   PubMed Web of Science ®Google Scholar
• KatzNBorensteinDGBirbaraCEfficacy and safety of tanezumab in the treatment of chronic low back painPain2011152102248225821696889
   PubMed Web of Science ®Google Scholar
• PfizerAn efficacy and safety study of tanezumab for the treatment of pain associated with chronic abacterial prostatitisClinicalTrials.gov [website on the Internet]Bethesda, MDUS National Library of Medicine2009 [updated March 14, 2011]. Available from: http://clinicaltrials.gov/ct2/show/study/NCT00826514?term=NCT00826514&rank=1. NLM identifier: NCT00826514Accessed April 15, 2012
   Google Scholar
• NickelJCAtkinsonGKriegerJTanezumab therapy for chronic prostatitis/chronic pelvic pain syndrome (cp/cpps): preliminary assessment of efficacy and safety in a randomized controlled trialThe Journal of Urology20111854e573e574
   Web of Science ®Google Scholar
• StraussACDimitrakovJDNew treatments for chronic prostatitis/chronic pelvic pain syndromeNat Rev Urol20107312713520142810
   PubMed Web of Science ®Google Scholar
• WoodJNNerve growth factor and painN Engl J Med102010363161572157320942675
   PubMed Web of Science ®Google Scholar
• PfizerSafety and efficacy of tanezumab in patients with chronic pancreatitisClinicalTrials.gov [website on the Internet]Bethesda, MDUS National Library of Medicine2010 [updated April 13, 2011]. Available from: http://clinicaltrials.gov/ct2/show/NCT01146561?term=NCT01146561&rank=1 NLM identifier: NCT01146561Accessed April 15, 2012
   Google Scholar
• AllsopSAErstadDJBrookKBhaiSFCohenJMDimitrakoffJDThe DABBEC Phenotyping System: towards a mechanistic understanding of CP/CPPSNat Rev Urol20118210711321243018
   PubMed Web of Science ®Google Scholar
• MahalBACohenJMAllsopSAThe role of phenotyping in chronic prostatitis/chronic pelvic pain syndromeCurr Urol Rep201112429730321533747
   PubMedGoogle Scholar
• MearesEMStameyTABacteriologic localization patterns in bacterial prostatitis and urethritisInvest Urol1968554925184870505
   PubMedGoogle Scholar
• StameyTAProstatitisJ R Soc Med198174122407007638
   PubMed Web of Science ®Google Scholar